American Enterprise Institute (AEI) president Arthur C. Brooks has announced that AEI scholar Leon R. Kass, M.D., is the recipient of AEI’s 2012 Irving Kristol Award. Dr. Kass will receive the award and deliver the Irving Kristol Lecture at AEI’s annual dinner on Wednesday, May 2, 2012, at the National Building Museum in Washington, D.C.

AEI contributorsfrom the federal government, foundation sector, and the nation's top scientists seek to define the major issues in ensuring continued U.S. leadership in biomedical research.

Successfully translating scientific discoveries requires a sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need. Patients waiting expectantly for medical research to produce important new cures are finding bad news almost everywhere they turn.

For the last decade, as the biopharmaceutical industry has struggled — largely unsuccessfully — to live up to its anticipated potential, a litany of experts, analysts, participants, and commentators have offered up their diagnosis and treatment for pharma’s productivity problem.

The basic question they’re all trying to solve: how can...

Theallocation of public funds should take account of both research productivity and the public health need to relieve the social and economic burden of disease.

In spite of what we spend on health care, research tells us that we only receive appropriate care half the time. We are simply not getting what we are paying for.

"We are at the cusp of a revolution in medicine and biotechnology," Sonia Arrison announces in "100+", "that will radically increase not just our life spans but also, and more importantly, our health spans." This revolution will "change everything, from careers and relationships to family and faith."

Alan D. Viard argues that monetary policy and automatic fiscal stabilizers provide the best response to the current downturn.